Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas

NCT00704691 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Closed due to futility with only 1 patient accrued

Conditions

Peripheral T-cell Lymphomas
Adult T-cell Leukemia
Adult T-cell Lymphoma
Peripheral T-cell Lymphoma Unspecified
Angioimmunoblastic T-cell Lymphoma
Anaplastic Large Cell Lymphoma
T/Null Cell Systemic Type
Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease

Interventions

DRUG: Lenalidomide

Sponsor

University of Alabama at Birmingham